Patent details
300604 Product Name: Combinatie van Neisseria meningitidis groep B NHBA-fusie-eiwit; Neisseria meningitidis groep B NadA-eiwit; en Neisseria meningitidis groep B fHbp-fusie-eiwit
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300604
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1549338
- Status:
- SPC in force
- Application number:
- 300604
- Procedural language:
- Dutch
- First Applicant Residence Country:
- Switzerland (CH)
Paediatric Extension
- SPC Extension Filing Date:
- 05/01/2026
- SPC Extension Agent/Owner Name:
- ir. F.A. Geurts c.s. , GlaxoSmithKline Biologicals S.A.
- SPC Extension Status:
- Extension Granted
- SPC Extension Grant Date:
- 16/01/2026
- SPC Extension Request Refusal Date:
- SPC Extension Revocation Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/12/812/001-004
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 18/01/2013
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 15/07/2013
- First Marketing Authorization date:
- 18/01/2013
- Grant date:
- 22/09/2016
- Activation date:
- 02/10/2023
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 15/07/2013
- SPC/SPC Extension Expiration Date:
- 17/07/2028
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 22/12/2021
- Name:
- GlaxoSmithKline Biologicals S.A.
- Address:
- Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Historical Applicant/holder
- From:
- 29/07/2014
- To:
- 22/12/2021
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- From:
- 15/07/2013
- To:
- 29/07/2014
- Name:
- Novartis Vaccines and Diagnostics S.r.l.
- Address:
- Via Fiorentina 1, 53100 SIENA (SI), Italy (IT)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 21/02/2018
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC
- Journal edition number:
- 03/26
- Publication date:
- 21/01/2026
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 01/26
- Publication date:
- 07/01/2026
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 40/23
- Publication date:
- 04/10/2023
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- CO
- Journal edition number:
- 05/22
- Publication date:
- 02/02/2022
- Description:
- Changes in the Netherlands Patent Register
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 39/16
- Publication date:
- 28/09/2016
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
6
- Bulletin Heading:
- CO
- Journal edition number:
- 2014/39
- Publication date:
- 24/09/2014
- Description:
- Changes in the Netherlands Patent Register
7
- Bulletin Heading:
- SPC
- Journal edition number:
- 2013/31
- Publication date:
- 31/07/2013
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202102715A
- Date Registered:
- 22/12/2021
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- GlaxoSmithKline Biologicals S.A.
- Address:
- Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- 022527-A022527-1
- Date Registered:
- 29/07/2014
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Other
- Note:
Annual Fee
- Annual Fee(s) Due Date:
- 31/10/2026
- Annual Fee Number:
- 24
- Annual Fee Amount:
- 2200 Euro
- Last Annual Payment Date:
- 23/09/2025
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 2000 Euro
- Payer:
- Anaqua Services
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 16/01/2026 | Outgoing Correspondence | Decision extension duration | 1 | /4/0/6/0/0/0400300604/docs/300604_22_300604691522l504c.pdf | ||
| 16/01/2026 | Certificate | Certificate | 1 | /4/0/6/0/0/0400300604/docs/300604_23_spcxcertificate20260116100859630.pdf | ||
| 05/01/2026 | Application Form | First filed application form | 3 | /4/0/6/0/0/0400300604/docs/300604_15_applicationform20260105020316913.pdf | ||
| 05/01/2026 | SPC Documents | Summary of the characteristics of the product | 20 | /4/0/6/0/0/0400300604/docs/300604_16_supplprotectioncertificate20260105020444346.pdf | ||
| 05/01/2026 | SPC Documents | Annex SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_17_supplprotectioncertificate20260105020344299.pdf | ||
| 05/01/2026 | SPC Documents | Annex SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_18_supplprotectioncertificate20260105020533346.pdf | ||
| 05/01/2026 | SPC Documents | Annex SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_19_supplprotectioncertificate20260105020511593.pdf | ||
| 05/01/2026 | SPC Documents | Marketing Authorization SPC | 3 | /4/0/6/0/0/0400300604/docs/300604_20_supplprotectioncertificate20260105020552422.pdf | ||
| 05/01/2026 | Outgoing Correspondence | Confirmation receipt request for extension | 2 | /4/0/6/0/0/0400300604/docs/300604_21_300604689516l505.pdf | ||
| 19/02/2018 | Incoming Correspondence Paper | Correspondence address details | 1 | /4/0/6/0/0/0400300604/docs/300604_14_incomingcorrespondencepaper20180221113415474.pdf | ||
| 17/11/2016 | Outgoing Correspondence | Outgoing Letter | 1 | /4/0/6/0/0/0400300604/docs/300604_12_outgoingcorrespondence20161118092946039.pdf | ||
| 17/11/2016 | SPC Documents | Certificate SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_13_supplprotectioncertificate20161118092946110.pdf | ||
| 04/11/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /4/0/6/0/0/0400300604/docs/300604_4_incomingcorrespondencepaper20161107033700172.pdf | ||
| 22/09/2016 | SPC Documents | Certificate SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_9_supplprotectioncertificate20201008103019471.pdf | ||
| 22/09/2016 | SPC Documents | Decision SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_10_supplprotectioncertificate20201008104010217.pdf | ||
| 22/06/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /4/0/6/0/0/0400300604/docs/300604_2_incomingcorrespondencepaper20160627040314094.pdf | ||
| 22/06/2016 | SPC Documents | Annex SPC | 1 | /4/0/6/0/0/0400300604/docs/300604_7_supplprotectioncertificate20201008104302044.pdf | ||
| 03/06/2014 | Incoming Correspondence Paper | Accompanying letter incoming document | 6 | /4/0/6/0/0/0400300604/docs/300604_6_incomingcorrespondencepaper20140603.pdf | ||
| 20/03/2014 | Outgoing Correspondence | Outgoing Letter | 2 | /4/0/6/0/0/0400300604/docs/300604_1_outgoingcorrespondence20140320.pdf | ||
| 22/07/2013 | Outgoing Correspondence | Outgoing Letter | 1 | /4/0/6/0/0/0400300604/docs/300604_3_outgoingcorrespondence20130722.pdf | ||
| 19/07/2013 | Application Form | First filed application form | 4 | /4/0/6/0/0/0400300604/docs/300604_0_applicationform20130719.pdf | ||
| 19/07/2013 | SPC Documents | Summary of the characteristics of the product | 31 | /4/0/6/0/0/0400300604/docs/300604_5_supplprotectioncertificate20201008104741447.pdf | ||
| 19/07/2013 | SPC Documents | Marketing Authorization SPC | 3 | /4/0/6/0/0/0400300604/docs/300604_8_supplprotectioncertificate20201008104610290.pdf | ||
| 19/07/2013 | SPC Documents | Marketing Authorization SPC | 4 | /4/0/6/0/0/0400300604/docs/300604_11_supplprotectioncertificate20201008104937193.pdf |